SATB2 is a novel biomarker and therapeutic target for cancer

Several studies have confirmed the involvement of cancer stem cells (CSC) in tumour progression, metastasis, drug resistance and cancer relapse. SATB2 (special AT‐rich binding protein‐2) acts as a transcriptional co‐factor and modulates chromatin architecture to regulate gene expression. The purpose...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Sanjit K., Shrivastava, Anju, Srivastav, Sudesh, Shankar, Sharmila, Srivastava, Rakesh K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576221/
https://www.ncbi.nlm.nih.gov/pubmed/32885593
http://dx.doi.org/10.1111/jcmm.15755

Ejemplares similares